
A device programmer showing the suspension of ICD therapies (orange bar, red arrow) with iPhone 12 laying over patient’s chest (green arrow) and fluoroscopy of iPhone 12 showing the circular magnet array (yellow arrow). Read the full study
January 8, 2020 — A new study published this week in HeartRhythm, the journal of the Heart Rhythm Society (HRS), found...
Videos | EP Device Monitoring Systems | December 22, 2020
Robert Kowal, M.D., chief medical officer of the Medtronic cardiac rhythm and heart failure division, said there has...

Chest X-ray from a patient included in the study. Posteroanterior view, of a 79-year-old man with history of a previous pacemaker, with abandoned right atrial and right ventricular pacing leads on the right side at time of new cardiac resynchronization therapy defibrillator implant on the left side. Arrows indicate a nodular opacity in the right midlung concerning for mass. Find more images of patients in this study in Radiology: Cardiothoracic Imaging.
October 27, 2020 – Magnetic resonance imaging (MRI) examinations can be safely performed in patients with non-MR...
News | EP Lab | September 08, 2020
September 8, 2020 - A new study presented at the 2020 European Society of Cardiology (ESC) Congress shows that...
News | EP Lab | July 13, 2020
July 13, 2020 - The U.S. Food and Drug Administration (FDA) has approved Abbott's next-generation Gallant implantable...
Videos | HRS | May 22, 2020
Interview with Andrew D. Krahn, M.D., FHRS, head of the division of cardiology at St. Paul’s Hospital, and professor of...
News | EP Lab | May 12, 2020
May 12, 2020 — Medtronic has received U.S. Food and Drug Administration (FDA) approval for its Cobalt and Crome ...
May 8, 2020 — Final results from the UNTOUCHED study of the Emblem Subcutaneous Implantable Defibrillator (S-ICD)...

The Boston Scientific Emblem MRI-safe S-ICD system does not require a transvenous lead, leading to fewer complications with this type of ICD.
May 8, 2020 — A new clinical trial is the first to compare the safety and efficacy of subcutaneous implantable...

Valentina Kutyifa, M.D., Ph.D., University of Rochester Medical Center, Rochester, N.Y., is doing research in the BIO-LIBRA Study to determine it ICD or CRT-D devices work better in men or women with heart failure often present with non-ischemic cardiomyopathy.
Feature | Cardiac Resynchronization Therapy Devices (CRT) | March 09, 2020 | Valentina Kutyifa M.D., Ph.D.
Cardiovascular disease is the leading cause of death for women in North America, and women with heart failure often...

Earlier this year, Medtronic began a worldwide pivotal study evaluating its investigational Extravascular Implantable Cardioverter Defibrillator (EV ICD) system to treat dangerously fast heart rhythms. The EV ICD system is designed to deliver lifesaving defibrillation and pacing therapy via a device the same size as traditional, transvenous ICDs, but with a lead (thin wire) placed outside the heart and veins.
Feature | EP Lab | November 11, 2019 | Hrishikesh Kadam
Cardiac rhythm management (CRM) devices in use today are evolving to raise the bar beyond monitoring and managing...

One of the cardiology technologies in the list of top advances in 2019 is Medtronic’s Tyrx Absorbable Antibacterial Envelope using to enclose cardiac implantable electronic devices (CIEDs). It reduced the risk of major infection by 40 percent, and pocket infection by 61 percent, based on data presented at ACC 2019.
News | November 06, 2019
November 6, 2019 — Cleveland Clinic announced the Top 10 Medical Innovations for 2020 at a multimedia presentation last...
October 11, 2019 — Medtronic plc announced the start of a worldwide pivotal study evaluating its investigational...
September 18, 2019 — Early use of an implantable cardioverter-defibrillator (ICD) after primary coronary intervention...
News | Leads Implantable Devices | August 05, 2019
August 5, 2019 — Abbott is recalling the Ellipse Implantable Cardioverter Defibrillators (ICDs) because electrical...